breast cancer and estrogen · pdf filedavid t. zava, phd founder, ceo, chief research...
TRANSCRIPT
David T. Zava, PhD Founder, CEO, Chief Research Scientist ZRT Laboratory
Breast Cancer And
Estrogen Metabolism
E ER
XENOESTROGENS (eg, DDT)
POLLUTANTS
XENOBIOTICS (eg, PCBs)
ESTROGENS (E1, E2)
PROGESTERONE
PROLACTIN
SHBG
THYROID
MELATONIN
CORTISOL
17B-HSD TYPE II (E1→E2) E1-SULFATASE (E1-S04 →E1) AROMATASE (A →E1)
BREAST STROMA
IMMUNE CYTOKINES SYSTEM TH1 ↓ TH2 ↑
DHEA
ADRENAL GLAND
STRESS
Emotional Physical Surgical
OVARIAN DYSFUNCTION
HEAVY METALS
ZINC SMOKING
POOR DIET (refined carbohydrates)
INSULIN
OBESITY
INSULIN RESISTANCE
TESTOSTERONE
(AROMATASE) LH/FSH
POLYCYSTIC OVARIES
ERT HRT
HORMONAL RISK FACTORS FOR BREAST CANCER THE ESTROGEN MATRIX
Vitamin D3
Iodine (I2)
2-OH-E1(E2)
E2 E1-S04 E1
16-OH-E1 4-OH-E1(E2)
4-QUINONE-E1(E2) 2-QUINONE-E1(E2) PROTEIN BINDING
DNA ADDUCT FORMATION
DNA ADDUCT FORMATION
NO FURTHER EFFECT
DNA REPAIR DNA DAMAGE MUTATION
CANCER
Sulfotransferase
Sulfatase
17 ß-HSD-Type II
17ß-HSD-Type I
E1 = ESTRONE
E2 =ESTRADIOL
E3 = ESTRIOL
E3
GST-GSH conjugation of 2- & 4-Quinone E1(E2)
COMT-Methylation of 2- & 4-OH –E1(E2)
INACTIVE ESTROGEN
METABOLITES
ESTROGEN METABOLISM AND BREAST CANCER RISK
Cyp-1A1
2-MeO-E1(E2)
4-MeO-E1(E2)
2-GS-E1(E2)
4-GS-E1(E2)
2-OH-E1(E2)
E2 E1-S04 E1
16-OH-E1 4-OH-E1(E2)
4-QUINONE-E1(E2) 2-QUINONE-E1(E2) PROTEIN BINDING
DNA ADDUCT FORMATION
DNA ADDUCT FORMATION
NO FURTHER EFFECT
DNA REPAIR DNA DAMAGE MUTATION
CANCER
Sulfotransferase
Sulfatase
17 ß-HSD-Type II
17ß-HSD-Type I
E1 = ESTRONE
E2 =ESTRADIOL
E3 = ESTRIOL
E3
GST-GSH conjugation of 2- & 4-Quinone E1(E2)
COMT-Methylation of 2- & 4-OH –E1(E2)
INACTIVE ESTROGEN
METABOLITES
ESTROGEN METABOLISM AND BREAST CANCER RISK
Cyp-1A1
2-MeO-E1(E2)
4-MeO-E1(E2)
2-GS-E1(E2)
4-GS-E1(E2)
Different types of body fluids commonly
used for testing hormones
Serum and Plasma (Venipuncture)
Urine (Liquid and Dry)
Saliva
Capillary Blood (Finger Stick Dried Blood Spots)
Dried Urine Test
Chinese-US (ZRT) Urine Steroid Hormone
Metabolite Breast Cancer Study
Eric Shi, PhD, MD, David Zava, PhD et.al. 37 Chinese premenopausal breast cancer patients-newly diagnosed, no Tx 42 Healthy age-matched controls Morning spot urine collections on filter paper-dried-shipped to ZRT at ambient temperature Steroids extracted from filter paper, SPE, enzyme hydrolyzed, liquid extracted, dried, derivatized, analyzed by GC-MS/MS.
Internal Research Results on Estrogen Metabolites and
Breast Cancer (to be published)
- 4-OH-Estrogens higher in breast cancer patients than controls - Selenium low in controls and breast cancer patients but statistically lower in patients
2-OH-E1(E2)
E2 E1-S04 E1
16-OH-E1 4-OH-E1(E2)
4-QUINONE-E1(E2) 2-QUINONE-E1(E2) PROTEIN BINDING
DNA ADDUCT FORMATION
DNA ADDUCT FORMATION
NO FURTHER EFFECT
DNA REPAIR DNA DAMAGE MUTATION
CANCER
Sulfotransferase
Sulfatase
17 ß-HSD-Type II
17ß-HSD-Type I
E1 = ESTRONE
E2 =ESTRADIOL
E3 = ESTRIOL
E3
GST-GSH conjugation of 2- & 4-Quinone E1(E2)
COMT-Methylation of 2- & 4-OH –E1(E2)
INACTIVE ESTROGEN
METABOLITES
ESTROGEN METABOLISM AND BREAST CANCER RISK
Cyp-1A1
2-MeO-E1(E2)
4-MeO-E1(E2)
2-GS-E1(E2)
4-GS-E1(E2)
2-OH-E1(E2)
E2 E1-S04 E1
16-OH-E1 4-OH-E1(E2)
4-QUINONE-E1(E2) 2-QUINONE-E1(E2) PROTEIN BINDING
DNA ADDUCT FORMATION
DNA ADDUCT FORMATION
NO FURTHER EFFECT
DNA REPAIR DNA DAMAGE MUTATION
CANCER
Sulfotransferase
Sulfatase
17 ß-HSD-Type II
17ß-HSD-Type I
E1 = ESTRONE
E2 =ESTRADIOL
E3 = ESTRIOL
E3
GSH Transferase
COMT
INACTIVE ESTROGEN
METABOLITES
ESTROGEN METABOLISM AND BREAST CANCER RISK
Cyp-1A1
2-MeO-E1(E2)
4-MeO-E1(E2)
2-GS-E1(E2)
4-GS-E1(E2)
E ER
XENOESTROGENS (eg, DDT)
POLLUTANTS
XENOBIOTICS (eg, PCBs)
ESTROGENS (E1, E2)
PROGESTERONE
PROLACTIN
SHBG
THYROID
MELATONIN
CORTISOL
17B-HSD TYPE I (E1→E2) E1-SULFATASE (E1-S04 →E1) AROMATASE (A →E1)
BREAST STROMA
IMMUNE CYTOKINES SYSTEM TH1 ↓ TH2 ↑
DHEA
ADRENAL GLAND
STRESS
Emotional Physical Surgical
OVARIAN DYSFUNCTION
CADMIUM
ZINC SMOKING
POOR DIET (refined carbohydrates)
INSULIN
OBESITY
INSULIN RESISTANCE
TESTOSTERONE
(AROMATASE) LH/FSH
POLYCYSTIC OVARIES
ERT HRT
HORMONAL RISK FACTORS FOR BREAST CANCER THE ESTROGEN MATRIX
Vitamin D3
Iodine (I2)
Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival. JNCI 92: 994-1000, 2000.
Normal Profile: Cortisol high morning, low night Breast Cancer Profile: Flat Diurnal Cortisol, high at night
Normal
Cancer
Normal Healthy Adult: Cortisol and Melatonin
Circadian Rhythm
Typical Cancer Patient: Cortisol and Melatonin
Circadian Rhythm
E ER
XENOESTROGENS (eg, DDT)
POLLUTANTS
XENOBIOTICS (eg, PCBs)
ESTROGENS (E1, E2)
PROGESTERONE
PROLACTIN
SHBG
THYROID
MELATONIN
CORTISOL
17B-HSD TYPE II (E1→E2) E1-SULFATASE (E1-S04 →E1) AROMATASE (A →E1)
BREAST STROMA
IMMUNE CYTOKINES SYSTEM TH1 ↓ TH2 ↑
DHEA
ADRENAL GLAND
STRESS
Emotional Physical Surgical
OVARIAN DYSFUNCTION
HEAVY METALS
ZINC SMOKING
POOR DIET (refined carbohydrates)
INSULIN
OBESITY
INSULIN RESISTANCE
TESTOSTERONE
(AROMATASE) LH/FSH
POLYCYSTIC OVARIES
ERT HRT
HORMONAL RISK FACTORS FOR BREAST CANCER THE ESTROGEN MATRIX
Vitamin D3
Iodine (I2)
TYPICAL URINARY HORMONE PROFILE IN BREAST CANCER PATIENTS
ESTRADIOL & ESTRONE
4-OH-E1 & 4-OH-E2 RATIO 4-MeO-E1/4-OH-E1
PREGNANEDIOL RATIO PREGNANE/PREGNENE
TESTOSTERONE & DHT EPI-TESTOSTERONE
DHEA DIURNAL CORTISOL (FLAT)
DIURNAL MELATONIN
TYPICAL SALIVARY AND BLOOD (DBS) HORMONE PROFILE IN BREAST CANCER
PATIENTS
ESTRADIOL & ESTRONE PROGESTERONE
RATIO PROGESTERONE/ESTRADIOL TESTOSTERONE
DHEA(S) DIURNAL CORTISOL (FLAT)